Pepdox
Studies
Peptides
Calculator
Home
/
Search
/
PMID 34962530
Semaglutide's Weight-Loss Benefits Were Sustained in a 2-Year Study.
JAMA
2021
PMID: 34962530
View on PubMed
DOI: 10.1001/jama.2021.21717
Semaglutide
Authors
Slomski, Anita
Semaglutide's Weight-Loss Benefits Were Sustained in a 2-Year Study. | Pepdox